Company intelligence / Profile preview
Gerolymatos International
- Ownership
- Private
- Employees
- ~96
- Development stage
- Other
Overview
Gerolymatos International is a long-established Greek pharmaceutical and healthcare company operating globally, with commercialized product lines in medical devices (notably hypertonic seawater-based nasal sprays Sinomarin), dermocosmetics (Foltene Pharma), and natural laxatives (Tamarine), distributed in over 50 countries[1][3].
- Therapeutic areas
- GastroenterologyPulmonologyDermatology
- Modalities
- Medical device (e.g., nasal and ear sprays)Small molecule (applies to certain OTC and veterinary products, but not confirmed for all)
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Gerolymatos International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gerolymatos International.